Evidence map›Paper›PMID 37644045›Full record

ArticleNature communications2023

Next generation synthetic memory via intercepting recombinase function.

Andrew E Short, Dowan Kim, Prasaad T Milner, Corey J Wilson

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Toward DNA-Based Recording of Biological Processes.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew E Short *Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-9053-8880
Dowan Kim *Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-7784-1743
Prasaad T MilnerGeorgia Institute of Technology, School of Chemical and Biomolecular Engineering, Atlanta, GA, USA.
Corey J WilsonGeorgia Institute of Technology, School of Chemical and Biomolecular Engineering, Atlanta, GA, USA. corey.wilson@chbe.gatech.edu.ORCID http://orcid.org/0000-0003-3040-1676

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we present a technology to facilitate synthetic memory in a living system via repurposing Transcriptional Programming (i.e., our decision-making technology) parts, to regulate (intercept) recombinase function post-translation. We show that interception synthetic memory can facilitate programmable loss-of-function via site-specific deletion, programmable gain-of-function by way of site-specific inversion, and synthetic memory operations with nested Boolean logical operations. We can expand interception synthetic memory capacity more than 5-fold for a single recombinase, with reconfiguration specificity for multiple sites in parallel. Interception synthetic memory is ~10-times faster than previous generations of recombinase-based memory. We posit that the faster recombination speed of our next-generation memory technology is due to the post-translational regulation of recombinase function. This iteration of synthetic memory is complementary to decision-making via Transcriptional Programming - thus can be used to develop intelligent synthetic biological systems for myriad applications.

Indexed as

Chromosome InversionIntelligenceHumansNonoxynolRecombinasesTechnologyNonoxynolRecombinases

Identifiers

PMID37644045
PMCPMC10465543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.